Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Mild Alzheimer's Disease
NCT01843075Phase 2Unknown
- Sponsor
- Imperial College London
- Start
- Jan 2014
- Primary completion
- Dec 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in Alzheimer's disease (AD), sponsored by Imperial College London. Status: unknown.
02
Drugs
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01843075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843075.